These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1295414)

  • 41. A possible role for propranolol in the treatment of renal osteodystrophy.
    Caro JF; Besarab A; Burke JF; Glennon JA
    Lancet; 1978 Aug; 2(8087):451-4. PubMed ID: 79809
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serum markers of bone turnover in dialyzed patients grouped by level of intact parathyroid hormone.
    Grzegorzewska AE; Mlot-Michalska M
    Adv Perit Dial; 2006; 22():203-6. PubMed ID: 16983970
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bone alkaline phosphatase isoforms in hemodialysis patients with low versus non-low bone turnover: a diagnostic test study.
    Haarhaus M; Monier-Faugere MC; Magnusson P; Malluche HH
    Am J Kidney Dis; 2015 Jul; 66(1):99-105. PubMed ID: 25843703
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hyperparathyroid bone disease in diabetic renal failure.
    Cundy TF; Humphreys S; Watkins PJ; Parsons V
    Diabetes Res; 1990 Aug; 14(4):191-6. PubMed ID: 2132193
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term dialysis with low-calcium solution (1.0 mmol/L) in CAPD: effects on bone mineral metabolism. Collaborators of the Multicenter Study Group.
    Weinreich T; Ritz E; Passlick-Deetjen J
    Perit Dial Int; 1996; 16(3):260-8. PubMed ID: 8761540
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term experience of alfacalcidol in renal osteodystrophy.
    Sharman VL; Brownjohn AM; Goodwin FJ; Hately W; Manning RM; O'Riordan JH; Papapoulos SE; Marsh FP
    Q J Med; 1982; 51(203):271-8. PubMed ID: 7146311
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of 1 alpha-hydroxycholecalciferol and 25-hydroxycholecalciferol in the treatment of renal osteodystrophy: greater effect of 25-hydroxycholecalciferol on bone mineralization.
    Fournier A; Bordier P; Gueris J; Sebert JL; Marie P; Ferrière C; Bedrossian J; DeLuca HF
    Kidney Int; 1979 Feb; 15(2):196-204. PubMed ID: 513484
    [No Abstract]   [Full Text] [Related]  

  • 48. Pattern of renal osteodystrophy in haemodialysis patients in Saudi Arabia.
    Huraib S; Souqqiyeh MZ; Aswad S; al-Swailem AR
    Nephrol Dial Transplant; 1993; 8(7):603-8. PubMed ID: 8396743
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Renal osteodystrophy: alpha-Heremans Schmid glycoprotein/fetuin-A, matrix GLA protein serum levels, and bone histomorphometry.
    Coen G; Ballanti P; Balducci A; Grandi F; Manni M; Mantella D; Pierantozzi A; Ruggeri M; Sardella D; Sorbo G; Bonucci E
    Am J Kidney Dis; 2006 Jul; 48(1):106-13. PubMed ID: 16797392
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bone turnover markers predict type of bone histomorphometry and bone mineral density in Asian chronic haemodialysis patients.
    Laowalert S; Khotavivattana T; Wattanachanya L; Luangjarmekorn P; Udomkarnjananun S; Katavetin P; Eiam-Ong S; Praditpornsilpa K; Susantitaphong P
    Nephrology (Carlton); 2020 Feb; 25(2):163-171. PubMed ID: 30980579
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Loss of bone substance in long-term dialysis--the value of serochemical parameters].
    Schober HC; Abendroth K; Osten B; Kunkel S
    Z Urol Nephrol; 1989 Oct; 82(10):515-9. PubMed ID: 2609801
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of biochemical with radiological findings in renal osteodystrophy.
    Moorhead JF; Varghese Z; Tatler GL; Baillod RA; Wills MR
    Ann Clin Biochem; 1975 May; 12(3):126-31. PubMed ID: 15637920
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evidence for a relationship between plasma immunoreactive calcitonin and bone disease in chronic renal failure.
    Kanis JA; Heynen G; Earnshaw M; Russell RG; Woods CG; Franchimont P; Gaspar S; Oliver D; Ledingham JG
    Adv Exp Med Biol; 1977; 81():571-9. PubMed ID: 899941
    [No Abstract]   [Full Text] [Related]  

  • 54. Renal osteodystrophy in children undergoing continuous ambulatory peritoneal dialysis.
    Hewitt IK; Stefanidis C; Reilly BJ; Kooh SW; Balfe JW
    J Pediatr; 1983 Nov; 103(5):729-34. PubMed ID: 6631599
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Renal osteodystrophy in predialysis and hemodialysis patients: comparison of histologic patterns and diagnostic predictivity of intact PTH.
    Coen G; Ballanti P; Bonucci E; Calabria S; Costantini S; Ferrannini M; Giustini M; Giordano R; Nicolai G; Manni M; Sardella D; Taggi F
    Nephron; 2002 May; 91(1):103-11. PubMed ID: 12021526
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bone Biopsy Results in Chronic Kidney Disease: a Single-Center Experience.
    Liangos O; Kirchhoff S; Buchholz J; Ketteler M
    Kidney Blood Press Res; 2018; 43(4):1222-1230. PubMed ID: 30071519
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 25-hydroxyvitamin D levels and bone histomorphometry in hemodialysis renal osteodystrophy.
    Coen G; Mantella D; Manni M; Balducci A; Nofroni I; Sardella D; Ballanti P; Bonucci E
    Kidney Int; 2005 Oct; 68(4):1840-8. PubMed ID: 16164662
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Low calcium dialysate and hyperparathyroidism.
    Duncan R; Cochrane T; Bhalla C; Michael J; Richards NT; Adu D
    Perit Dial Int; 1996; 16 Suppl 1():S499-502. PubMed ID: 8728256
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy.
    Jehle PM; Ostertag A; Schulten K; Schulz W; Jehle DR; Stracke S; Fiedler R; Deuber HJ; Keller F; Boehm BO; Baylink DJ; Mohan S
    Kidney Int; 2000 Feb; 57(2):423-36. PubMed ID: 10652019
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Osteocalcin, iPTH, alkaline phosphatase and hand X-ray scores as predictive indices of histomorphometric parameters in renal osteodystrophy.
    Mazzaferro S; Coen G; Ballanti P; Bondatti F; Bonucci E; Pasquali M; Sardella D; Tomei E; Taggi F
    Nephron; 1990; 56(3):261-6. PubMed ID: 2077408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.